Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Overweight 1Obesity 1Neoplasms 1Intermittent Fasting 1Carcinoma, Hepatocellular 1

Interventions

Tirzepatide 9Exercise 5Counseling 4semaglutide 3Resistance Training 3Methods 3Standard of Care 2Progestins 2Nutrition Assessment 2Megestrol Acetate 2Diet Therapy 2mirabegron 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1atezolizumab 1Weights and Measures 1Walk Test 1Vitamin D 1Urine Specimen Collection 1Trehalase 1Topiramate 1Therapeutics 1Tablets 1TIC10 compound 1Surveys and Questionnaires 1Stents 1Spermine Synthase 1Specimen Handling 1Sampling Studies 1Qsymia 1Psychology, Positive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity × Diet, Healthy × 1 year × Clear all
NCT06824974 2025-08-08

TRE+HE

University of California, San Diego

Phase NA Recruiting
50 enrolled
GastrointestinalOther

Intermittent Fasting, Carcinoma, Hepatocellular, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡